Monthly Archives: August 2024

Business & Investments

Response Plus Holding revenue surges 24%to AED 209.88 million in the first half of 2024

Group reports net profit of AED 27.17 million; Assets surge 17% to AED 351 million

Abu Dhabi, United Arab Emirates, August 13, 2024: Response Plus Holding PJSC (ADX: RPM), the largest pre-hospital care and emergency medical services provider in the UAE and KSA, has released its interim half-year results for the period ending on June 30th, 2024.

The group’s revenue surged to AED 209.88 million in the first half of 2024, compared to AED 168.77 million in H1 2023, registering a 24% year-on-year growth.Over the first six months of 2024, RPM’s net profit was AED 27.17 million after tax.

Continue reading Response Plus Holding revenue surges 24%to AED 209.88 million in the first half of 2024 →
Business & Investments

AD Ports Group Delivers an Impressive 56% YoY Increase in EBITDA and 42% Growth in Total Net Profit in Q2 2024

Abu Dhabi, UAE – 13 August 2024:

Condensed Consolidated Profit & Loss

  1. EBITDA is calculated by taking net profit and adding depreciation and amortization, finance costs, income tax expense, impairment of investment properties and subtracting government grants, fair value gain on pre-existing interest in a joint venture and finance income
  2. Based on the weighted average number of shares for the period
Continue reading AD Ports Group Delivers an Impressive 56% YoY Increase in EBITDA and 42% Growth in Total Net Profit in Q2 2024 →
Real Estate

ENBD REIT Announces Sale of Remraam Residential Towers

  • Sale price represents slight premium to 31 March 2024 market value
  • Divestment in line with turnaround strategy for growth and portfolio optimisation
  • Proceeds deployed to reduce debt with LTV down to 49.4%

Dubai, United Arab Emirates, 13 August2024:ENBD REIT(CEIC) PLC (“ENBD REIT”), the Shari’a compliant real estate investment trust managed by Emirates NBD Asset Management Limited, has announced the successful sale of the Remraam residential assets at a slight premium to market value at 31 March 2024.

The decision to divest this asset is in line with ENBD REIT’s turnaround strategy to optimize its portfolio with a focus on dividend growth viaproactive asset management. The proceeds from this sale will be utilized to reduce debt, resulting in the LTV ratio dropping to 49.4% from 51%.

Continue reading ENBD REIT Announces Sale of Remraam Residential Towers →
Business & Investments

WakeCap confirms key role in improving construction safety throughout Saudi Arabia

WakeCap’s smart solution for construction site management presented to the Kingdom’s Ministry of Industry and Mineral Resources, prompting a directive to establish regulations for its adoption

Photo caption: His Excellency Bandar I. Alkhorayef, the Minister of Industry and Mineral Resources and His Excellency Mr. Khalil Ibn Salamah, the Deputy Minister for Industrial Affairs with Dr. Hassan Albalawi, CEO and Founder of WakeCap

Riyadh, Saudi Arabia; 13August 2024:WakeCap, a workforce safety and productivity solution,  showcased its smart construction site management technologies to the Kingdom’s Ministry of Industry and Mineral Resources, which will see the company at the forefront of safety improvement in mining and manufacturing projects across the Kingdom.

Continue reading WakeCap confirms key role in improving construction safety throughout Saudi Arabia →
Business & Investments

STADA acquires FITO™ from LEO Pharma and expands Consumer Healthcare in the MENA Region

  • STADA acquires LEO Pharma existing FITO trademark in the GCC, North Africa, the Middle East and selected Asian Countries.
  • STADA EVP Emerging Markets Stephane Jacqmin: “We look forward to leveraging our local marketing and sales platform to develop the full potential of this strong brand in the many markets of the MENA region. This will strengthen STADA’s role as the partner of choice in consumer healthcare and support our growth in this region”

Dubai12August2024 – The pharmaceutical company STADA is expanding its consumer healthcare business in the MENA region with the acquisition of FITO™ from LEO Pharma. The medical device is based on the wheat extract Rigenase (DamorFarmaceutici, Italy) and is indicated for the dermatological treatment of first- and second-degree burns, ulcers, wounds and abrasions. The herbal origin has a high safety profileand forms a protective barrier against the external environment.

Continue reading STADA acquires FITO™ from LEO Pharma and expands Consumer Healthcare in the MENA Region →